Association of Increased Risk of Pneumonia and Using Proton Pump Inhibitors in Patients With Type II Diabetes Mellitus.

Wen-Ling LinChin-Shin MuoWen-Chuan LinYow-Wen HsiehChia-Hung Kao

Published in: Dose-response : a publication of International Hormesis Society (2019)

The results of this population-based retrospective cohort study suggest that PPI use increased the risk of pneumonia in patients with T2DM. The effects were more prominent in patients administered higher doses of PPIs.

Keyphrases

end stage renal disease
ejection fraction
peritoneal dialysis
type diabetes
glycemic control
patient reported outcomes
small molecule
respiratory failure
community acquired pneumonia